Grantylon- An MHRA accredited facility for Non-Beta- Lactam Solid Oral Dosages, built exclusively for Contract Manufacturing in Regulated Markets. In association with international organizations, the Grantylon facility is instrumental in Global Sourcing.
Our state- of- the- art equipment is capable of manufacturing solid oral dosages in immediate release and delayed release forms along with hard gelatine capsules. The facility is well equipped with a state-of-the-art analytical lab to support the manufacturing process with the latest advancements supporting microbiology. The facility Is capable of supplying both small-scale clinical trial quantities and commercial-scale requirements. Our end-to-end services offer a compelling value proposition to our global customers.
RESEARCH & DEVELOPMENT
Our R&D enables development of pharmaceutical formulations and caters to the various needs of our global clientele. The R&D facility is state-of-the-art set up for formulation development and analytical development. The facility is designed and equipped to conform to stringent international standards. This new facility is in complete compliance with cGMP, cGLP and ICH guidelines in conducting the R&D activities along with full regulatory compliance to EU-DMF and US-DMF. In-depth exposure to literature search, patent search and preparation of pre-formulation Studies allows us to conduct extensive analysis on new prototype formulations and to check the feasibility of a product; development and optimization of Formula; process improvement; preparation of stability batches; accelerated stability studies and many more intricacies in formulation development. The R&D operations, as a whole, will have a direct impact on the commercial manufacturing batches, costing and in providing utmost satisfaction to our customers worldwide.
The R&D facility will empower us to file dossiers for the ever-growing UK, Australia and European markets and emerging ROW markets. This facility will offer a one-stop solution from development to formulation, dossier making to commercial production.